PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
ED  - Axelsson, Anna
TI  - Losartan Lacks Benefit in Inherited HCM
DP  - 2014  01
TA  - MD Conference Express
PG  - 18--19
VI  - 14
IP  - 52
4099  - http://mdc.sagepub.com/content/14/52/18.short
4100  - http://mdc.sagepub.com/content/14/52/18.full
AB  - Hypertrophic cardiomyopathy (HCM) has a prevalence of 1 in every 500 individuals, making it the most frequently inherited cardiomyopathy, and it results in the fibrosis and hypertrophy of the left ventricle. This article discusses data from the Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy [INHERIT; NCT01447654] trial, which investigated the use of losartan for HCM.